Aftate Triple Antibiotic (Sabel Med LLC)
Welcome to the PulseAid listing for the Aftate Triple Antibiotic drug offered from Sabel Med LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sabel Med LLC |
NON-PROPRIETARY NAME: | Triple Antibiotic Ointment |
SUBSTANCE NAME: | POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2016-05-01 |
END MARKETING DATE: | 0000-00-00 |
Aftate Triple Antibiotic HUMAN OTC DRUG Details:
Item Description | Aftate Triple Antibiotic from Sabel Med LLC |
LABELER NAME: | Sabel Med LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5000; 3.5; 400([iU]/g; mg/g; [iU]/g) |
START MARKETING DATE: | 2016-05-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70356-101_2f6e9a84-895d-492d-e054-00144ff8d46c |
PRODUCT NDC: | 70356-101 |
APPLICATION NUMBER: | part333B |
Other POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC Pharmaceutical Manufacturers / Labelers: